Clinical Trials Sponsored by Pharmacyclics LLC.
Total 10746 results
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia With 17p Deletion | Small Lymphocytic Lymphoma With 17p DeletionUnited States, United Kingdom, Belgium, Germany, Turkey, Australia, Canada, New Zealand, Sweden
-
Janssen Research & Development, LLCPharmacyclics LLC.Completed
-
Janssen Research & Development, LLCPharmacyclics LLC.Completed
-
Pharmacyclics LLC.Janssen, LPCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Pharmacyclics LLC.Celgene CorporationTerminatedMultiple MyelomaUnited States, Spain, Australia, Czechia, Germany, Greece
-
Northwestern UniversityPharmacyclics LLC.WithdrawnLymphoma | Brain and Central Nervous System Tumors | Neurotoxicity
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLeukemia, Lymphocytic, Chronic, B-CellCanada, Belgium, Netherlands, Spain, Israel, United States, Czechia, Denmark, United Kingdom, France, Russian Federation, Turkey, Poland, Sweden
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingMantle Cell LymphomaUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Israel, Turkey, Ukraine, Japan, Canada, Greece, Korea, Republic of, Netherlands, Brazil, Russian Federation, Puerto Rico, Australia, I... and more
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Italy, New Zealand, Poland, Spain
-
Pharmacyclics LLC.Janssen Research & Development, LLCActive, not recruitingChronic Graft Versus Host DiseaseUnited States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Belgium, Canada, China, Czechia, Ireland, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedWaldenström's MacroglobulinemiaUnited States, Spain, France, Canada, Germany, Italy, Australia, United Kingdom, Greece
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, Australia, France, Poland, United Kingdom, China, Belgium, Germany, Spain, Israel, Turkey, Ukraine, Japan, Taiwan, Canada, Denmark, Finland, Korea, Republic of, Netherlands, Brazil, Russian Federation, Argentina, Norway, Swed... and more
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, France, Poland, Belgium, Germany, Spain, Argentina, Colombia, Israel, Portugal, Russian Federation, Turkey, Ukraine, Canada, Greece, Sweden, Korea, Republic of, United Kingdom, Brazil, Mexico, Czechia
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, Taiwan, Malaysia, Australia
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaFrance, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Colombia, Portugal, Ukraine, Canada, Netherlands, Sweden, Korea, Republic of, Chile, Brazil, Russian Federation, Hungary, Ireland, Mexico, Czechia
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Belgium, Canada, China, Czechia, Ireland, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, Australia, France, Poland, United Kingdom, Spain, Belgium, Germany, Russian Federation
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaUnited States, France, United Kingdom, Belgium, Spain, Israel, Puerto Rico, Poland, Russian Federation
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedHealthy VolunteersUnited States
-
Oncternal Therapeutics, IncPharmacyclics LLC.WithdrawnImmune System Diseases | Lymphoma | Lymphoma, B-Cell | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell
-
Pharmacyclics LLC.Ohio State UniversityCompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's Transformation | Prolymphocyctic LeukemiaUnited States
-
Pharmacyclics LLC.AstraZeneca; Janssen Research & Development, LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States
-
Northside Hospital, Inc.Pharmacyclics LLC.Terminated
-
Janssen Biotech, Inc.Pharmacyclics LLC.Approved for marketingRelapsed or Refractory Mantle Cell LymphomaUnited States, Brazil, Puerto Rico
-
Janssen Pharmaceutical K.K.Pharmacyclics LLC.CompletedRecurrent Mature B-cell NeoplasmsJapan
-
US Oncology ResearchAbbVie; Pharmacyclics LLC.Active, not recruitingBreast Neoplasms | Malignant Neoplasm of BreastUnited States
-
Dana-Farber Cancer InstitutePharmacyclics LLC.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
University of California, DavisPharmacyclics LLC.CompletedMetastatic Renal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | Small Lymphocytic LeukemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Completed
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Completed
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Terminated
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.Active, not recruitingMarginal Zone LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.Active, not recruitingPrimary Central Nervous System Lymphoma (PCNSL) | Secondary Central Nervous System Lymphoma (SCNSL)United States
-
University of California, San DiegoPharmacyclics LLC.Active, not recruitingHead and Neck Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States
-
University of California, San DiegoPharmacyclics LLC.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Pharmacyclics Switzerland GmbHJanssen Research & Development, LLCCompletedMultiple MyelomaSpain, Germany, Turkey, Greece, Italy, Czechia
-
M.D. Anderson Cancer CenterAmgen; Pharmacyclics LLC.Terminated
-
AbbVieJanssen Research & Development LLC; Pharmacyclics LLC (An AbbVie Company)CompletedCoronaVirus Induced Disease-2019 (COVID-19)United States
-
Dana-Farber Cancer InstituteAbbVie; Pharmacyclics LLC.Active, not recruitingWaldenstrom Macroglobulinemia | MYD88 Gene MutationUnited States
-
Washington University School of MedicinePharmacyclics LLC.Completed
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.WithdrawnChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | CLL/SLL | SLLUnited States
-
Georgetown UniversityAbbVie; Pharmacyclics LLC.; Hackensack Meridian HealthActive, not recruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
Brian JonasPharmacyclics LLC.CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Refractory Anemia With Excess Blasts in TransformationUnited States
-
Michael ChoiPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Michael ChoiPharmacyclics LLC.Withdrawn
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.TerminatedHigh Risk Smoldering Multiple MyelomaUnited States